Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody–drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer

J.F. Liu, Kathleen N. Moore, Michael J. Birrer, S. Berlin, Ursula A. Matulonis, J. R. Infante, Brian M. Wolpin, Kirsten Achilles Poon, Ron Firestein, Jian Xu,

Annals of Oncology · 2016 · 140 citations · 12 references

DOIFull text

Open access

Concepts

References

12